Native cytosolic protein phosphatase-1 (PP-1S) containing modulator (inhibitor-2) is an active enzyme  by Bollen, Mathieu et al.
FEBS Letters 344 (1994) 196-200 
LETTERS 
FEBS 14006 
ELSEVIER 
Native cytosolic protein phosphatase- 1 (PP-1 S) containing modulator 
(inhibitor-2) is an active enzyme 
Mathieu BollerF*, Anna A. DePaoli-Roachb, Willy StaIrnan? 
“Afdeling Biochemie. Fakulteit Geneeskunde, Katholieke Universiteit Leuven. B-3000 Leuven, Belgium 
bDepartment of Biochemistry and Molecular Biology, Indiana University School of Medecine. Indianapolis, IN 46202-5122, USA 
Received 24 March 1994 
Abstract 
In vitro, the modulator protein (inhibitor-2) slowly converts the catalytic subunit of protein phosphatase-1 (PP-1,) into an inactive ‘MgATP- 
dependent form’ that can be reactivated by the transient phosphorylation of modulator with GSK-3/F,. We report here that this modulator-induced 
inactivation of PP-1, can be blocked by addition (at pH 7.5) of either 0.3 mM NaF or 150 mM N&l, or by raising the pH to 8.5. Making use of 
a combination of the latter conditions, we have partially purified a soluble modulator-associated form of PP-1 (PP-1s) from rabbit skeletal muscle 
as a spontaneously active enzyme that cannot be further activated by kinase GSK-3/F,. These observations argue against a role for the ‘MgATP- 
dependent’ form of PP-IS as an inactive reservoir of PP-1,. PP-1s was separated on aminohexyl Sepharose from another active, cytosolic species 
of PP-1, which appears to be a proteolytic product of the glycogen-bound PP-1G. 
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1. Introduction 
Within the rapidly expanding group of SerlThr-spe- 
cific protein phosphatases, the type- 1 enzymes (PP- 1) are 
easily identified by the unique structure and enzymic 
properties of their catalytic subunit (reviewed in [ 11). For 
example, only the catalytic subunit of PP-1 is inhibited 
by specific cytoplasmic (inhibitor-l and inhibitor-2 or 
modulator) and nuclear (NIPP- 1) polypeptides [ 1,2]. 
The type-l catalytic subunit (PP-1.) appears to con- 
tain two binding sites for the modulator protein [l]. 
Binding of modulator to a low-affinity binding site 
causes an instantaneous inhibition of the catalytic sub- 
unit, while the association of modulator with a high- 
affinity binding site results in a slow (t,,* of lo-30 min 
at 30°C) transition of the catalytic subunit into an inac- 
tive conformation. One can differentiate between inhibi- 
tion and inactivation of the catalytic subunit by appro- 
priate phosphatase assays: inhibition is released upon 
destruction of modulator by trypsin, which removes also 
the carboxyterminal part of the catalytic subunit with 
little effect on its activity. On the other hand, the inactive 
‘MgATP-dependent’ phosphatase, consisting of modula- 
tor and inactive PP-l,-, can only be reactivated either by 
* Corresponding author. Fax: (32) (16) 345995. 
Abbreviations: GSK3/F,, glycogen synthase kinase-3, also termed pro- 
tein kinase F,; PP-1, protein phosphatase-1; PP-IS, soluble (cytosolic) 
PP- 1; PP- 1 G, glycogen-bound protein phosphatase- 1; PP- I,, catalytic 
subunit of protein phosphatase-1. 
trypsin in the presence of Mn2+ or by phosphorylation 
of modulator with GSK-3/F,. 
The ‘MgATP-dependent’ phosphatase has also been 
purified from muscle and brain cytosol [l]. Combined 
with findings that some isoforms of PP-1, are produced 
in bacteria in their inactive conformation, these data 
have been taken as evidence that the association of inac- 
tive PP-1, with modulator represents an intermediate 
step in the generation of different PP-1 holoenzymes [3]. 
After reactivation by GSK-3/F,, the catalytic subunit 
would then become available for association with other 
targeting subunits of PP-1. 
The above hypothesis implies that the cytosolic (solu- 
ble) species of PP- 1, which we termed PP-1 S [ 11, is at least 
partially present in its inactive, MgATP-dependent form 
in vivo. Previous studies have indicated that inactive 
enzyme is indeed present to a measurable extent in mus- 
cle extracts [4,5]. However, since PP- 1 S is gradually inac- 
tivated after tissue homogenization [6-Q, it is difficult to 
assess the amount of PP-1s in its MgATP-dependent 
form in vivo. A detailed study of agents and conditions 
that interfere with the modulator-induced inactivation of 
purified PP-1, has enabled us to select homogenization 
conditions that should virtually freeze the modulator- 
associated phosphatase in its native state of activation. 
Using these tools, we were unable to detect a cytosolic 
pool of inactive, MgATP-dependent protein phosphat- 
ase in skeletal muscle. The modulator protein emerges 
from our studies as a (noninhibitory) subunit of a spon- 
taneously active phosphatase. 
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2. Experimental 
2.1. Materials and assays 
The catalytic subunit of PP-I [9], modulator [lo] and GSK-3/F, [l l] 
were purified from rabbit skeletal muscle. Phosphorylase, phosphory- 
lase kinase and particulate glycogen were prepared as described previ- 
ously [12]. Antibodies against rabbit skeletal muscle modulator were 
raised in a goat [13]. A synthetic peptide encompassing the protein 
kinase A phosphorylation site of the G-subunit of PP-1 G (R,) was used 
to raise antibodies in guinea pigs [14]. 
Buffer A contained 50 mM Tris (pH 8.0 at 4°C) 0.5 mM dithiothre- 
itol, 15 mM 2-mercaptoethanol, 0.3 mM NaF and 100 mM NaCl. 
Buffer B contained 50 mM Tris (pH 7.0 at 4”C), 0.5 mM dithiothreitol 
and 15 mM 2-mercaptoethanol. 
The phosphorylase phosphatase activity was measured either as such 
(‘spontaneous’ activity) or after preincubation with trypsin, which re- 
veals also the activity of catalytic subunit that is inhibited by modulator 
or other subunits; or still after a preincubation with GSK-3/F, followed 
by a trypsin treatment, which reveals, in addition, the activity of the 
MgATP-dependent enzyme [ 151. 
2.2. Partial puriJication of cytosolic phosphorylase phosphatase 
About 500 g of muscle from the back and hind legs of a rabbit were 
homogenized in 3 volumes of either buffer A or buffer B, containing 
in addition 250 mM sucrose. 0.5 mM benzamidine. 0.3 mM phen- 
ylmethanesulfonyl fluoride, 0.3 mM EGTA, 1 mM EDTA, 0.i mM 
L-lL4’-tosylamino-2-phenylethyl-chloromethyl ketone, 0.1 mM l- 
chloro-3-tosylamido-7-amino-2-heptanonehydrochloride, 4 pug/ml le- 
upeptin and 4 yg/ml pepstatin. Successive centrifugations at 8,000 x g 
(10 min) and 140,000 x g (60 min) yielded a ‘cytosolic’ fraction, which 
was stirred for 60 min at 4°C with 200 ml DEAE Sephadex A50, 
equilibrated with either buffer A or B. After washing with 5 ~01s. buffer 
on a glass funnel, the gel was poured into a column. All the cytosolic 
phosphorylase phosphatase activity was retained by the resin and was 
subsequently eluted with a linear 800-ml gradient of WI.5 M NaCl in 
either buffer A or buffer B. The phosphatase-containing fractions were 
pooled, diluted with 1 volume 0.3 mM NaF, and applied to a 30-ml 
column of aminohexyl Sepharose 4B, equilibrated in the correspond- 
ing buffer. The column was washed with 30 ml buffer, and developed 
with a 300-ml gradient of O-0.7 M NaCl in either buffer A or buffer 
B (Fig. 4). 
3. Results 
3.1. Inhibitors of the modulator-induced inactivation of 
PP-I c 
We have previously shown that the conversion of type- 
1 protein phosphatases to the inactive, MgATP-depend- 
ent form is blocked by low concentrations of fluoride (0.3 
mM), that are insufficient to inhibit the phosphatase 
activity [15]. However, fluoride was unable to prevent 
totally the gradual inactivation of the modulator-associ- 
ated phosphatase (PP-1s) that is observed during purifi- 
cation from skeletal muscle cytosol (not shown). This 
prompted us to investigate in more detail the conditions 
that offer protection against inactivation by modulator. 
While the addition of 0.3 mM NaF blocked completely 
the modulator-induced inactivation of PP-1, at pH 7.5 
(Fig. lB), fluoride did not display this effect at the acidic 
pH (Fig. 1A) that can be observed in skeletal muscle 
extracts prepared in weak neutral buffers. Unexpectedly, 
the pH itself also affected the modulator-mediated inac- 
tivation of PP-1,. While an incubation in the absence of 
fluoride for 60 min at pH 6.5 (Fig. 1A) or 7.5 (Fig. 1B) 
resulted in 80% inactivation of the catalytic subunit, vir- 
tually no inactivation occurred at pH 8.5 (Fig. 1C). The 
pH also interfered with the sensitivity of the free catalytic 
subunit to inhibition by fluoride. Thus, the concentra- 
tion of fluoride that caused 50% inhibition increased 
from about 0.5 mM at pH 6.5 to 3 mM at pH 7.5, and 
to about 20 mM at pH 8.5 (Fig. 1). 
Fig. 2 shows the effect of the pH on the time-depend- 
ent inactivation of PP- 1 c by modulator. While the inacti- 
vation rate was similar at pH 6.5 and 7.5, a slight further 
increase of the pH to 8.0 blocked the modulator-induced 
inactivation nearly completely. On the other hand, the 
activity of the free catalytic subunit did not change signif- 
icantly during incubation for 60 min at any of these pH 
values (not shown). 
In Fig. 3 it is demonstrated that KC1 also protected 
PP-1, against inactivation by modulator at pH 7.5. The 
addition of 30 mM KC1 decreased the inactivation rate 
about 3-fold and 150 mM caused a complete block. A 
similar protection against inactivation was obtained with 
the same concentrations of NaCl, NaBr or NaI (not 
shown). Addition of 150 mM KC1 after 30 min of incuba- 
tion with modulator also resulted in an instantaneous 
block of further inactivation of the phosphatase (Fig. 3). 
It appears therefore that salt does not interfere with the 
rapid association of catalytic subunit with modulator, 
but blocks the subsequent inactivation, which is a very 
slow process [15]. In gel filtration experiments, we have 
checked directly that this conclusion also applies to the 
composite effect of buffer A, which includes 0.1 M NaCl 
and 0.3 mM NaF at pH 8.0 (not shown). 
3.2. Activity of native PP-IS 
When the cytosolic fraction of rabbit skeletal muscle 
was prepared in a ‘classical’ buffer (i.e. at pH 7.0 without 
salt), only one spontaneously active species of 
phosphorylase phosphatase could be identified after con- 
secutive chromatographies on DEAE Sephadex A50 (not 
shown) and aminohexyl Sepharose 4B (Fig. 4A). How- 
ever, an additional species of phosphorylase phosphat- 
ase, which was eluted earlier, was revealed after preincu- 
bation of the fractions with GSK-3/F, under phospho- 
rylating conditions (Fig. 4A), or after preincubation with 
trypsin in the presence of Mn2+ (not shown). Since this 
additional species was not revealed by a preincubation 
of the fractions with trypsin alone, it must contain PP- 1 c 
in its inactive, MgATP-dependent conformation. More- 
over, the activity profile of the MgATP-dependent phos- 
phatase overlapped perfectly with the distribution of 
modulator, measured either immunologically or as heat- 
stable inhibitor of PP-1, (not shown). 
After partial purification of the cytosolic phosphatases 
from skeletal muscle in a buffer at pH 8.0, and in the 
presence of 0.3 mM NaF and 100 mM NaCl, two spon- 
taneously active species of phosphorylase phosphatase 
could be detected (Fig. 4B). The first peak of activity 
could only be increased about 30% by trypsin, whether 
or not the fractions had been pretreated with GSK-3/F, 
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Fig. 1. Dependence on the pH of the interaction of fluoride with PP-1, and with its inactivation by modulator. The type-l catalytic subunit (2 nM) 
was incubated for 60 min at 25°C in a buffer containing 10 mM MES, 10 mM imidazole, 10 mM Tris and 1 mM dithiothreitol, at pH 6.5 (left panel), 
or at pH 7.5 (middle panel), or else at pH 8.5 (right panel). Modulator (0.2 ,uM) and NaF were added as indicated. After this incubation, additions 
were made for the assay of the trypsin-resistant phosphorylase phosphatase activity, causing an additional dilution of 1.7-fold. The results represent 
the means f S.E.M. for 4 experiments. In comparison with pH 7.5, the activity of the free catalytic subunit amounted to 86 f 17% at pH.6.5 and 
69 f 2% at pH 8.5. 
under phosphorylating conditions. This small increase 
by trypsin can be explained by proteolysis of the car- 
boxyterminal domain of the catalytic subunit [l]. Fol- 
lowing dialysis against buffer at pH 7.0 without salt or 
fluoride (buffer B), the firstly eluted phosphatase could 
be converted to the inactive, MgATP-dependent form by 
incubation at 30°C (not shown). Moreover, the distribu- 
tion of modulator coincided perfectly with the first peak 
of phosphatase activity (not shown). Taken together 
these data indicate that the first eluted phosphatase rep- 
resents an active form of the modulator-associated en- 
zyme. The properties of the second peak of phosphory- 
lase phosphatase were similar to the corresponding peak 
obtained after purification at pH 7.0. 
3.3. IdentiJication of a soluble form of PP-1 G 
Several lines of evidence suggest that the phosphatase 
eluted from aminohexyl Sepharose after the modulator- 
associated phosphatase represents a form of PP-1G that 
has lost its affinity for glycogen and/or membranes. 
First, the enzyme could be affinity-purified by chroma- 
tography on/I-cyclodextrin Sepharose, which also specif- 
ically binds the glycogen-bound enzyme from rat liver 
[12] and from rabbit skeletal muscle (Wera, Bollen and 
Stalmans, unpublished). In contrast to PP-lG, however, 
the soluble enzyme did not co-sediment with glycogen, 
and remained also soluble when extra a-particulate gly- 
cogen (1%) was added before high-speed centrifugation 
(not shown). Second, as for muscle PP-1G [16], incuba- 
tion of the enzyme with protein kinase A under phospho- 
rylating conditions resulted in a dissociation of the cata- 
lytic subunit from the holoenzyme, as measured by a 
shift of the phosphatase during gel filtration to 35 kDa 
(not shown). Third, consistent with previous findings 
[17], the phosphatase purified by chromatography on 
/3_cyclodextrin Sepharose contained multiple polypep- 
tides that could be phosphorylated by protein kinase A. 
These polypeptides (30-100 kDa during SDS-PAGE) are 
likely to be proteolytically derived fragments of the G- 
subunit, since they were recognized by polyclonal anti- 
bodies raised against a synthetic peptide encompassing 
the protein kinase A phosphorylation site-l of the G- 
subunit (not shown). Moreover, phosphopeptide map- 
ping by reverse-phase chromatography indicated that 
the same two phosphopeptides were generated from each 
polypeptide by proteolysis with trypsin. These 
phosphopeptides migrated identically as previously de- 
scribed [ 171 for similarly isolated phosphopeptides from 
the G-subunit of PP-1G (not shown). 
Taken together, the above data strongly indicate that 
the type-l phosphatase eluting after PP-1s on ami- 
nohexyl Sepharose represents an artefact generated by 
proteolysis of the glycogen-binding domain of PP-1G. In 
agreement with this view, we found that the presence of 
‘soluble’ PP-1G was remarkably species-dependent: the 
enzyme could barely be detected after chromatography 
of a rat skeletal muscle cytosol on aminohexyl Sepharose 
(3 experiments; not shown). 
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Fig. 2. Effect of the pH on the time-dependent inactivation of PP-1, 
by modulator. The type-l catalytic subunit was incubated with modu- 
lator at the indicated pH values, as detailed in the legend to Fig. 1. At 
the indicated time points samples were taken for the assay of trypsin- 
resistant phosphorylase phosphatase activity. 
4. Discussion 
4.1. The interaction ofJIuoride with PP-1 
The present data confirm that the effect of fluoride on 
the modulator-mediated inactivation of PP-1 is unrelated 
to the inhibition of the phosphatase activity by fluoride. 
As was noted previously [ 1,151, there was a large differ- 
ence in IC,, between the two fluoride effects at pH 7.5 
(Fig. 1). Further, the two phenomena were very differ- 
ently affected by pH. The large variations with pH sug- 
gest that the fluoride effects are critically dependent on 
the state of ionization of specific groups. The increased 
sensitivity of the phosphatase to inhibition by fluoride at 
lower pH values may suggest that the actual phosphatase 
inhibitor is HF or HF,-, rather than F- [18]. In contrast, 
the sensitivity to fluoride of the modulator-mediated in- 
activation did not increase at lower pH and is therefore 
most likely due to F-. 
4.2. The activation state of PP-IS in vivo 
In keeping with the general agreement to name type-l 
protein phosphatases according to their cellular location, 
we have previously proposed the name PP-1S for the 
‘soluble’ (cytosolic) species of PP-1 [l]. Our present re- 
sults (section 3.3) suggest that one of the cytosolic species 
of PP-1 in rabbit skeletal muscle actually represents a 
proteolytically degraded form of the glycogen-associated 
phosphatase (PP- 1 G). Thus, the name PP-1 S solely refers 
to the modulator-associated phosphatase. 
The presence of spontaneously active PP-1s in vivo 
may be explained by the presence of inhibitors of the 
inactivation like salts (Fig. 3), inhibitor-l or Mg2+ [19], 
and/or by the continuous reactivation of the MgATP- 
dependent form by GSK-3/F,. Using high concentra- 
tions of Mg2+ to counteract the gradual inactivation of 
PP-1 S after tissue homogenization, Vandenheede et al. 
[20] previously also concluded that the catalytic subunit 
of this enzyme exists in the cell in an active conforma- 
tion. In contrast to their findings, however, we observed 
only a mild increase in the activity of PP-1S by a pretreat- 
ment with trypsin (Fig. 4). Although the reason for this 
discrepancy is not clear, our results show that modulator 
can form an active complex with the catalytic subunit, 
and does not function as a simple phosphatase inhibitor 
in vivo. 
The present findings also call for a revision of the 
physiological role of PP-1s. Recently, it has been pro- 
posed that modulator acts like a ‘chaperone’ that is re- 
quired for the GSK-3/F,-dependent activation of nas- 
cent PP-1, isoforms [3]. PP-1 S would then serve as a 
cytosolic reservoir of inactive PP-1, which, following 
reactivation by F,/GSK-3, would be directed to other 
cellular locations by transfer to specific targeting sub- 
units. However, under conditions that prevent inactiva- 
tion we could not detect a pool of cytosolic inactive 
PP-1s. As further support of the ‘chaperone’ hypothesis 
was invoked the finding that the glycogen-binding sub- 
unit and the myosin-binding subunit from muscle were 
able to displace the catalytic subunit from an active com- 
plex between modulator and PP-1, [3]. It should be 
noted, however, that the opposite is true for liver, where 
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Fig. 3. Effect of KC1 on the modulator-induced inactivation of PP-1,. 
The type-l catalytic subunit was incubated at pH 7.5 with modulator 
in the presence of the indicated concentrations of KCI, as explained in 
the legend to Fig. 1. At the indicated time points, aliquots were taken 
for the assay of trypsin-resistant phosphorylase phosphatase activity. 
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Fig. 4. Chromatography of cytosolic PP-1 on aminohexyl Sepharose. The cytosolic species of PP-1 were partially purified in buffer A (left panel) 
or buffer B (right panel), as described in the experimental section. The figure shows the elution of the phosphorylase phosphatase activity from 
aminohexyl Sepharose. The phosphorylase phosphatase activity was measured as such (c’), after a preincubation with trypsin (o), and after 
phosphorylation by GSK-3/F, followed by a trypsin treatment (r). 
modulator has been shown to dissociate the catalytic 
subunit from the glycogen-bound phosphatase [21]. In 
addition, Cohen and co-workers [22] reported that mod- 
ulator can form with muscle PP-1G a ternary complex 
which can be reactivated by F,/GSK-3. The formation 
of such a complex is difficult to reconcile with the pro- 
posed chaperone role of the modulator. 
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